Year |
Citation |
Score |
2020 |
Krook MA, Lenyo A, Wilberding M, Barker H, Dantuono M, Bailey KM, Chen HZ, Reeser JW, Wing MR, Miya J, Samorodnitsky E, Smith AM, Dao T, Martin DM, Ciombor KK, et al. Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma. Molecular Cancer Therapeutics. PMID 31911531 DOI: 10.1158/1535-7163.Mct-19-0631 |
0.315 |
|
2019 |
Krook MA, Barker H, Chen HZ, Reeser JW, Wing MR, Martin D, Smith AM, Dao T, Bonneville R, Samorodnitsky E, Miya J, Freud AG, Monk JP, Clinton SK, Roychowdhury S. Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 31043681 DOI: 10.1038/S41391-019-0145-2 |
0.31 |
|
2019 |
Chen HZ, Bonneville R, Yu L, Wing MR, Reeser JW, Krook MA, Miya J, Samorodnitsky E, Smith A, Martin D, Dao T, Guo Q, Liebner D, Freud AG, Allenby P, et al. Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy. Oncotarget. 10: 277-288. PMID 30719225 DOI: 10.18632/Oncotarget.26352 |
0.344 |
|
2019 |
Krook MA, Chen HZ, Bonneville R, Allenby P, Roychowdhury S. Rapid Research Autopsy: Piecing the Puzzle of Tumor Heterogeneity. Trends in Cancer. 5: 1-5. PMID 30616752 DOI: 10.1016/J.Trecan.2018.11.004 |
0.31 |
|
2019 |
Krook MA, Lenyo AM, Wilberding MJ, Barker HD, Dantuono M, Chen H, Reeser JW, Wing MR, Miya J, Samorodnitsky E, Smith AM, Dao T, Martin DM, Dittmar K, Ciombor KK, et al. Abstract 335: Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma Cancer Research. 79: 335-335. DOI: 10.1158/1538-7445.Am2019-335 |
0.336 |
|
2016 |
Kent LN, Rakijas JB, Pandit SK, Westendorp B, Chen HZ, Huntington JT, Tang X, Bae S, Srivastava A, Senapati S, Koivisto C, Martin CK, Cuitino MC, Perez M, Clouse JM, et al. E2f8 mediates tumor suppression in postnatal liver development. The Journal of Clinical Investigation. PMID 27454291 DOI: 10.1172/Jci85506 |
0.557 |
|
2012 |
Chen HZ, Ouseph MM, Li J, Pécot T, Chokshi V, Kent L, Bae S, Byrne M, Duran C, Comstock G, Trikha P, Mair M, Senapati S, Martin CK, Gandhi S, et al. Canonical and atypical E2Fs regulate the mammalian endocycle. Nature Cell Biology. 14: 1192-202. PMID 23064266 DOI: 10.1038/Ncb2595 |
0.701 |
|
2012 |
Ouseph MM, Li J, Chen HZ, Pécot T, Wenzel P, Thompson JC, Comstock G, Chokshi V, Byrne M, Forde B, Chong JL, Huang K, Machiraju R, de Bruin A, Leone G. Atypical E2F repressors and activators coordinate placental development. Developmental Cell. 22: 849-62. PMID 22516201 DOI: 10.1016/J.Devcel.2012.01.013 |
0.689 |
|
2011 |
Wenzel PL, Chong JL, Sáenz-Robles MT, Ferrey A, Hagan JP, Gomez YM, Rajmohan R, Sharma N, Chen HZ, Pipas JM, Robinson ML, Leone G. Cell proliferation in the absence of E2F1-3. Developmental Biology. 351: 35-45. PMID 21185283 DOI: 10.1016/J.Ydbio.2010.12.025 |
0.635 |
|
2010 |
Wang H, Karikomi M, Naidu S, Rajmohan R, Caserta E, Chen HZ, Rawahneh M, Moffitt J, Stephens JA, Fernandez SA, Weinstein M, Wang D, Sadee W, La Perle K, Stromberg P, et al. Allele-specific tumor spectrum in pten knockin mice. Proceedings of the National Academy of Sciences of the United States of America. 107: 5142-7. PMID 20194734 DOI: 10.1073/Pnas.0912524107 |
0.557 |
|
2010 |
Martinez LA, Goluszko E, Chen HZ, Leone G, Post S, Lozano G, Chen Z, Chauchereau A. E2F3 is a mediator of DNA damage-induced apoptosis. Molecular and Cellular Biology. 30: 524-36. PMID 19917728 DOI: 10.1128/Mcb.00938-09 |
0.495 |
|
2010 |
Wang H, Karikomi M, Naidu S, Rajmohan R, Caserta E, Chen H, Rawahneh M, Moffitt J, Stephens JA, Fernandez SA, Weinstein M, Perle KL, Stromberg P, Rosol TJ, Eng C, et al. Abstract 3260: Allele-specific tumor spectrum inPtenknockin mice Cancer Research. 70: 3260-3260. DOI: 10.1158/1538-7445.Am10-3260 |
0.559 |
|
2009 |
Chong JL, Wenzel PL, Sáenz-Robles MT, Nair V, Ferrey A, Hagan JP, Gomez YM, Sharma N, Chen HZ, Ouseph M, Wang SH, Trikha P, Culp B, Mezache L, Winton DJ, et al. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature. 462: 930-4. PMID 20016602 DOI: 10.1038/Nature08677 |
0.69 |
|
2009 |
Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nature Reviews. Cancer. 9: 785-97. PMID 19851314 DOI: 10.1038/Nrc2696 |
0.643 |
|
2008 |
Li J, Ran C, Li E, Gordon F, Comstock G, Siddiqui H, Cleghorn W, Chen HZ, Kornacker K, Liu CG, Pandit SK, Khanizadeh M, Weinstein M, Leone G, de Bruin A. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Developmental Cell. 14: 62-75. PMID 18194653 DOI: 10.1016/J.Devcel.2007.10.017 |
0.603 |
|
Show low-probability matches. |